[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.119.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 747
Citations 0
Editorial
September 2015

Cortical Lesions in Multiple SclerosisClinical Relevance for a Hidden Disease Burden

Author Affiliations
  • 1Department of Neurology, Washington University, St Louis, Missouri
JAMA Neurol. 2015;72(9):979-980. doi:10.1001/jamaneurol.2015.1422

The field of multiple sclerosis (MS) has benefited immensely from brain magnetic resonance imaging (MRI) scans as a biomarker of white matter inflammatory lesions. Magnetic resonance imaging has become an essential component of clinical practice to confirm diagnosis, identify new therapies, stratify disease severity, and monitor treatment response. Nearly 30 years ago, the discovery of white matter plaques fascinated the field and sparked a revolution toward understanding this disease. Initially, these MRI bright spots were met with some skepticism because early investigations suggested a murky relationship between T2-weighted signal changes and clinical outcomes.

First Page Preview View Large
First page PDF preview
First page PDF preview
×